ARCHIVES

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

This article is from The Cancer Letter archive.

Vol. 38 No. 38 | October 12, 2012

Download PDF Visit The Full Archive

Related Articles

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

8 Centers Awarded Comprehensive Designation

February 15, 1991